It was reported that a patient presented with grade 4+ mixed mitral regurgitation (mr), dilated atrium, anterior mitral leaflet flail, flail gap, right heart failure, a restricted posterior leaflet, and an ejection fraction of 10% for a mitraclip procedure.It was noted that the patient was very sick, and considered for a left ventricular assist device (lvad), but it was decided to attempt to treat him with a less invasive procedure.There was nothing wrong with the device, and the clip grasped the leaflets with out incident.Left ventricle (lv) and right ventricle (rv) function dropped when the clip was closed on the leaflet.Ef dropped to 5% and the patient went into peri-arrest with systolic pressure dropping to 60mmhg, and bradycardia.The clip was subsequently removed, and medication was administered by anesthesiology.Extracorporeal membrane oxygenation (ecmo) and a small non-abbott heart pump were placed to stabilize patient.The patient systemically couldn't handle the mitraclip intervention.Per the physician, the adverse event was not caused by the mitraclip devices, but the patient's comorbidities and not being able to handle the procedure.The patient was stable.
|
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Based on the information reviewed, a cause for the reported bradycardia, test results (ejection fraction dropping to 5%) and hypotension cannot be determined.Hypotension and bradycardia are listed in the instructions for use (ifu) as known possible complications associated with mitraclip procedures.Unexpected medical interventions and medication required were a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.
|